Keywords
Last Name
Institution

Dariusz Maciej Pytel

Title
InstitutionMedical University of South Carolina
DepartmentBiochemistry and Molecular Biology
AddressP.O. Box MSC 509
HO 709
Hollings Cancer Center - 86 Jonathan Lucas St.
Phone843-792-6837
Fax843-792-8304
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rozpedek W, Pytel D, Wawrzynkiewicz A, Siwecka N, Dziki A, Dziki L, Diehl JA, Majsterek I. Use of small-molecule inhibitory compound of PERK-dependent signaling pathway as a promising target-based therapy for colorectal cancer. Curr Cancer Drug Targets. 2020 Jan 05. PMID: 31906838.
      View in: PubMed
    2. Siwecka N, Rozpedek W, Pytel D, Wawrzynkiewicz A, Dziki A, Dziki L, Diehl JA, Majsterek I. Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis. Int J Mol Sci. 2019 Sep 05; 20(18). PMID: 31491919.
      View in: PubMed
    3. Basak J, Rozpedek W, Pytel D, Majsterek I. Potential therapeutic application of PERK inhibitors Postepy Biochem. 2019 06 06; 65(2):118-127. PMID: 31642650.
      View in: PubMed
    4. Poplawski T, Pytel D, Dziadek J, Majsterek I. Interplay between Redox Signaling, Oxidative Stress, and Unfolded Protein Response (UPR) in Pathogenesis of Human Diseases. Oxid Med Cell Longev. 2019; 2019:6949347. PMID: 31089415.
      View in: PubMed
    5. Rozpedek W, Pytel D, Diehl JA, Majsterek I. [Niskoczasteczkowe inhibitory szlaku adaptacyjnej odpowiedzi na stres zaleznego od kinazy PERK jako nowatorska strategia terapeutyczna w leczeniu choroby Alzheimera]. Pol Merkur Lekarski. 2019 Jan 28; 46(271):9-15. PMID: 30810108.
      View in: PubMed
    6. Kowalczyk T, Sitarek P, Skala E, Toma M, Wielanek M, Pytel D, Wieczfinska J, Szemraj J, Sliwinski T. Induction of apoptosis by in vitro and in vivo plant extracts derived from Menyanthes trifoliata L. in human cancer cells. Cytotechnology. 2019 Feb; 71(1):165-180. PMID: 30610508.
      View in: PubMed
    7. Rozpedek W, Pytel D, Nowak-Zdunczyk A, Lewko D, Wojtczak R, Diehl JA, Majsterek I. Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment. Curr Med Chem. 2019; 26(8):1425-1445. PMID: 29345572.
      View in: PubMed
    8. Rozpedek W, Pytel D, Poplawski T, Walczak A, Gradzik K, Wawrzynkiewicz A, Wojtczak R, Mucha B, Diehl JA, Majsterek I. Inhibition of the PERK-Dependent Unfolded Protein Response Signaling Pathway Involved in the Pathogenesis of Alzheimer's Disease. Curr Alzheimer Res. 2019; 16(3):209-218. PMID: 30819079.
      View in: PubMed
    9. Skala E, Kowalczyk T, Toma M, Szemraj J, Radek M, Pytel D, Wieczfinska J, Wysokinska H, Sliwinski T, Sitarek P. Induction of apoptosis in human glioma cell lines of various grades through the ROS-mediated mitochondrial pathway and caspase activation by Rhaponticum carthamoides transformed root extract. Mol Cell Biochem. 2018 Aug; 445(1-2):89-97. PMID: 29238899.
      View in: PubMed
    10. Rozpedek W, Pytel D, Dziki L, Nowak A, Dziki A, Diehl JA, Majsterek I. Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatment. Pol Przegl Chir. 2017 Jun 30; 89(3):7-10. PMID: 28703114.
      View in: PubMed
    11. Sitarek P, Rijo P, Garcia C, Skala E, Kalemba D, Bialas AJ, Szemraj J, Pytel D, Toma M, Wysokinska H, Sliwinski T. Antibacterial, Anti-Inflammatory, Antioxidant, and Antiproliferative Properties of Essential Oils from Hairy and Normal Roots of Leonurus sibiricus L. and Their Chemical Composition. Oxid Med Cell Longev. 2017; 2017:7384061. PMID: 28191277.
      View in: PubMed
    12. Mucha B, Pytel D, Markiewicz L, Cuchra M, Szymczak I, Przybylowska-Sygut K, Dziki A, Majsterek I, Dziki L. Nucleotide Excision Repair Capacity and XPC and XPD Gene Polymorphism Modulate Colorectal Cancer Risk. Clin Colorectal Cancer. 2018 06; 17(2):e435-e441. PMID: 29793654.
      View in: PubMed
    13. Rozpedek W, Nowak A, Pytel D, Diehl JA, Majsterek I. Molecular Basis of Human Diseases and Targeted Therapy Based on Small-Molecule Inhibitors of ER Stress-Induced Signaling Pathways. Curr Mol Med. 2017; 17(2):118-132. PMID: 28266275.
      View in: PubMed
    14. Skala E, Rijo P, Garcia C, Sitarek P, Kalemba D, Toma M, Szemraj J, Pytel D, Wysokinska H, Sliwinski T. The Essential Oils of Rhaponticum carthamoides Hairy Roots and Roots of Soil-Grown Plants: Chemical Composition and Antimicrobial, Anti-Inflammatory, and Antioxidant Activities. Oxid Med Cell Longev. 2016; 2016:8505384. PMID: 28074117.
      View in: PubMed
    15. Pytel D, Gao Y, Mackiewicz K, Katlinskaya YV, Staschke KA, Paredes MC, Yoshida A, Qie S, Zhang G, Chajewski OS, Wu L, Majsterek I, Herlyn M, Fuchs SY, Diehl JA. PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma. PLoS Genet. 2016 Dec; 12(12):e1006518. PMID: 27977682.
      View in: PubMed
    16. Rozpedek W, Pytel D, Diehl JA, Majsterek I. [Small molecule inhibitors of PERK-dependent signaling pathway as a novel, therapeutic molecular strategy in Alzheimer's disease treatment]. Pol Merkur Lekarski. 2016 Jul 29; 41(241):5-10. PMID: 27734813.
      View in: PubMed
    17. Rozpedek W, Pytel D, Mucha B, Leszczynska H, Diehl JA, Majsterek I. The Role of the PERK/eIF2a/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress. Curr Mol Med. 2016; 16(6):533-44. PMID: 27211800.
      View in: PubMed
    18. Rozpedek W, Markiewicz L, Diehl JA, Pytel D, Majsterek I. [The role of the adaptive stress response in the pathogenesis of neurodegenerative diseases, cancer and diabetes mellitus type 2]. Pol Merkur Lekarski. 2015 Dec; 39(234):393-7. PMID: 26802695.
      View in: PubMed
    19. Cuchra M, Mucha B, Markiewicz L, Przybylowska-Sygut K, Pytel D, Jeziorski A, Kordek R, Majsterek I. The role of base excision repair in pathogenesis of breast cancer in the Polish population. Mol Carcinog. 2016 12; 55(12):1899-1914. PMID: 27870262.
      View in: PubMed
    20. Pytel D, Majsterek I, Diehl JA. Tumor progression and the different faces of the PERK kinase. Oncogene. 2016 Mar 10; 35(10):1207-15. PMID: 26028033.
      View in: PubMed
    21. Cuchra M, Markiewicz L, Mucha B, Pytel D, Szymanek K, Szemraj J, Szaflik J, Szaflik JP, Majsterek I. The role of base excision repair in the development of primary open angle glaucoma in the Polish population. Mutat Res. 2015 Aug; 778:26-40. PMID: 26056729.
      View in: PubMed
    22. Markiewicz L, Pytel D, Mucha B, Szymanek K, Szaflik J, Szaflik JP, Majsterek I. Altered Expression Levels of MMP1, MMP9, MMP12, TIMP1, and IL-1ß as a Risk Factor for the Elevated IOP and Optic Nerve Head Damage in the Primary Open-Angle Glaucoma Patients. Biomed Res Int. 2015; 2015:812503. PMID: 26120586.
      View in: PubMed
    23. Nowak A, Majsterek I, Przybylowska-Sygut K, Pytel D, Szymanek K, Szaflik J, Szaflik JP. Analysis of the expression and polymorphism of APOE, HSP, BDNF, and GRIN2B genes associated with the neurodegeneration process in the pathogenesis of primary open angle glaucoma. Biomed Res Int. 2015; 2015:258281. PMID: 25893192.
      View in: PubMed
    24. Rozpedek W, Markiewicz L, Diehl JA, Pytel D, Majsterek I. Unfolded Protein Response and PERK Kinase as a New Therapeutic Target in the Pathogenesis of Alzheimer's Disease. Curr Med Chem. 2015; 22(27):3169-84. PMID: 26282939.
      View in: PubMed
    25. Pytel D, Seyb K, Liu M, Ray SS, Concannon J, Huang M, Cuny GD, Diehl JA, Glicksman MA. Enzymatic Characterization of ER Stress-Dependent Kinase, PERK, and Development of a High-Throughput Assay for Identification of PERK Inhibitors. J Biomol Screen. 2014 Aug; 19(7):1024-34. PMID: 24598103.
      View in: PubMed
    26. Joshi RP, Schmidt AM, Das J, Pytel D, Riese MJ, Lester M, Diehl JA, Behrens EM, Kambayashi T, Koretzky GA. The ? isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling. Sci Signal. 2013 Nov 26; 6(303):ra102. PMID: 24280043.
      View in: PubMed
    27. Lee EK, Lian Z, D'Andrea K, Letrero R, Sheng W, Liu S, Diehl JN, Pytel D, Barbash O, Schuchter L, Amaravaradi R, Xu X, Herlyn M, Nathanson KL, Diehl JA. The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma. Mol Cell Biol. 2013 Nov; 33(22):4422-33. PMID: 24019069.
      View in: PubMed
    28. Chitnis N, Pytel D, Diehl JA. UPR-inducible miRNAs contribute to stressful situations. Trends Biochem Sci. 2013 Sep; 38(9):447-52. PMID: 23906563.
      View in: PubMed
    29. Slupianek A, Falinski R, Znojek P, Stoklosa T, Flis S, Doneddu V, Pytel D, Synowiec E, Blasiak J, Bellacosa A, Skorski T. BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability. Leukemia. 2013 Mar; 27(3):629-34. PMID: 23047475.
      View in: PubMed
    30. Chitnis NS, Pytel D, Bobrovnikova-Marjon E, Pant D, Zheng H, Maas NL, Frederick B, Kushner JA, Chodosh LA, Koumenis C, Fuchs SY, Diehl JA. miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner. Mol Cell. 2012 Nov 09; 48(3):353-64. PMID: 23022383.
      View in: PubMed
    31. Bobrovnikova-Marjon E, Pytel D, Riese MJ, Vaites LP, Singh N, Koretzky GA, Witze ES, Diehl JA. PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation. Mol Cell Biol. 2012 Jun; 32(12):2268-78. PMID: 22493067.
      View in: PubMed
    32. Slupianek A, Poplawski T, Jozwiakowski SK, Cramer K, Pytel D, Stoczynska E, Nowicki MO, Blasiak J, Skorski T. BCR/ABL stimulates WRN to promote survival and genomic instability. Cancer Res. 2011 Feb 01; 71(3):842-51. PMID: 21123451.
      View in: PubMed
    33. Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C, Cavener D, Diehl JA. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene. 2010 Jul 08; 29(27):3881-95. PMID: 20453876.
      View in: PubMed
    34. Rusin P, Walczak A, Zwierzchlejska A, Olszewski J, Morawiec-Bajda A, Kaczmarczyk D, Kusmierczyk K, Garncarek P, Pytel D, Sliwinnski T, Majsterek I. DNA damage and repair of head and neck cancer cells after radio- and chemotherapy. Z Naturforsch C J Biosci. 2009 Jul-Aug; 64(7-8):601-10. PMID: 19791515.
      View in: PubMed
    35. Pytel D, Sliwinski T, Poplawski T, Ferriola D, Majsterek I. Tyrosine kinase blockers: new hope for successful cancer therapy. Anticancer Agents Med Chem. 2009 Jan; 9(1):66-76. PMID: 19149483.
      View in: PubMed
    36. Pytel D, Slupianek A, Ksiazek D, Skórski T, Blasiak J. [Uracil-DNA glycosylases]. Postepy Biochem. 2008; 54(4):362-70. PMID: 19248582.
      View in: PubMed
    37. Slupianek A, Pytel D, Majsterek I. [The role of oncogenic tyrosine kinases in the cellular response to anticancer therapy]. Postepy Hig Med Dosw (Online). 2007 Dec 14; 61:819-27. PMID: 18097340.
      View in: PubMed
    38. Majsterek I, Arabski M, Czechowska A, Pytel D, Morawiec Z, Morawiec-Bajda A, Blasiak J. Imatinib (STI571) inhibits DNA repair in human leukemia oncogenic tyrosine kinase-expressing cells. Z Naturforsch C J Biosci. 2006 Nov-Dec; 61(11-12):896-902. PMID: 17294703.
      View in: PubMed
    39. Pytel D, Wysocki T, Majsterek I. Comparative study of DNA damage, cell cycle and apoptosis in human K562 and CCRF-CEM leukemia cells: role of BCR/ABL in therapeutic resistance. Comp Biochem Physiol C Toxicol Pharmacol. 2006 Sep; 144(1):85-92. PMID: 16904383.
      View in: PubMed
    40. Majsterek I, Sliwinski T, Poplawski T, Pytel D, Kowalski M, Slupianek A, Skorski T, Blasiak J. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair. Mutat Res. 2006 Jan 31; 603(1):74-82. PMID: 16388976.
      View in: PubMed
    41. Majsterek I, Pytel D, Blasiak J. [Tyrosine kinases. New target of anticancer therapy]. Postepy Biochem. 2005; 51(3):251-60. PMID: 16381169.
      View in: PubMed
    Pytel's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description